Stryker Corporation (SYK)
| Market Cap | 88.51B |
| Revenue (ttm) | 17.95B |
| Net Income (ttm) | 2.46B |
| Shares Out | 378.40M |
| EPS (ttm) | 6.43 |
| PE Ratio | 37.44 |
| Forward PE | 22.83 |
| Dividend | $2.78 (1.15%) |
| Ex-Dividend Date | Sep 29, 2022 |
| Volume | 1,662,687 |
| Open | 235.66 |
| Previous Close | 233.89 |
| Day's Range | 235.66 - 242.48 |
| 52-Week Range | 188.84 - 280.43 |
| Beta | 0.99 |
| Analysts | Buy |
| Price Target | 243.25 (+1.0%) |
| Earnings Date | Oct 31, 2022 |
About SYK
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgi... [Read more]
Financial Performance
In 2021, Stryker's revenue was $17.11 billion, an increase of 19.21% compared to the previous year's $14.35 billion. Earnings were $1.99 billion, an increase of 24.70%.
Financial StatementsAnalyst Forecast
According to 34 analysts, the average rating for SYK stock is "Buy." The 12-month stock price forecast is 243.25, which is an increase of 1.03% from the latest price.
News
Here's Why You Should Retain Stryker (SYK) Stock For Now
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.
Stryker opens the OR of the Future for customers to experience tomorrow's OR today
This operating room model puts increased focus on design for patient and staff safety, productivity and operational efficiency—further enabling improvements in quality of care FLOWER MOUND, Texas , Nov....
Final Trades: Uber, IBM, Stryker & more
The "Halftime Report" traders give their top picks to watch for the second half.
2 Under-the-Radar Medtech Stocks to Buy Now
Don't count out these discounted medical technology stocks.
Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
Kalamazoo, Michigan, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022.
Stryker's (SYK) Q3 Earnings Miss Estimates, Volume Improves
Stryker's (SYK) third-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurt sales growth.
Stocks moving on earnings: Stryker, Pitney Bowes, Hologic
Yahoo Finance's Julie Hyman breaks down some trending tickers on the move following earnings.
Stryker (SYK) Misses Q3 Earnings Estimates
Stryker (SYK) delivered earnings and revenue surprises of -5.36% and 0.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Stryker Corp. stock falls after company lowers outlook for 2022
Shares of Stryker Corp. SYK, +0.00% fell more than 4% in the extended session Monday after the maker of surgical equipment and other medical devices reported third-quarter results above analyst expectat...
Stryker reports third quarter 2022 operating results
Kalamazoo, Michigan, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2022:
3 Medical Stocks On the Rebound
As surgeries bounce back toward pre-pandemic levels, these three companies should benefit.
Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting
KALAMAZOO, Mich.
Stryker Launches Monterey AL Interbody System with New Pre-clinical Data
KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker launched its Monterey AL Interbody System, a stand-alone interbody fusion device designed for anterior lumbar interbody fusion.
Stryker to host conference call on October 31, 2022
Kalamazoo, Michigan, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's ...
Stryker (SYK) Launches Q Guidance System for Spine Applications
Stryker's (SYK) Q Guidance System is expected to be a procedural ecosystem for surgeons during guided spine surgery following its launch.
Stryker Launches Q Guidance System with Spine Guidance Software
KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker announced the launch of its Q Guidance System for spine applications.
Stryker's (SYK) OptaBlate Tumor Ablation System Gets FDA Nod
Stryker's (SYK) OptaBlate bone tumor ablation system is set to offer a reliable solution for people living with painful metastatic tumors.
3 Undervalued Dividend Champions With High Return Potential
Income investors sometimes take the route of finding the best income stocks to meet their needs based upon criteria like dividend safety, dividend growth potential or historical dividend streak. These c...
Diamon Hill CEO names a ‘mispriced' medical technology stock
Stryker Corporation (NYSE: SYK) is a “mispriced” stock that has potential to offer lucrative returns over the long term, says Heather Brilliant. She's the Chief Executive of Diamon Hill Capital Management.
There's always an opportunity to find mispriced stocks, says Diamond Hill CEO Heather Brilliant
Heather Brilliant, Diamond Hill Capital Management president and CEO, joins CNBC's 'Squawk Box' ahead of the open on Tuesday to break down potential investment opportunities.
Stryker receives FDA clearance for OptaBlate™ Bone Tumor Ablation System
Stryker's first bone tumor ablation system with patented microinfusion technology offers a reliable solution for people living with painful metastatic tumors PORTAGE, Mich., USA, Sept.
Should You Buy Stryker Stock Around $225?
Stryker stock (NYSE: SYK), a medical devices company, has seen a 15% fall this year, in line with the broader S&P500 index, down 17%.
Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Mee...
KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker launched its Pulse Intelligent Delivery Platform, which will debut at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting.